Financings Roundup

• Trius Therapeutics Inc., of San Diego, said underwriters of its previously announced public offering exercised in full their option to purchase an additional 1.29 million shares to cover overallotments. Including the overallotment, the company grossed $51.9 million from the sale of 9.89 million shares priced at $5.25 apiece.